Fresenius Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . Fresenius Medical Care
FMS Stock  USD 20.93  0.44  2.06%   
Fresenius Medical financial statements provide useful quarterly and yearly information to potential Fresenius Medical Care investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Fresenius Medical financial statements helps investors assess Fresenius Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Fresenius Medical's valuation are summarized below:
Gross Profit
5.3 B
Profit Margin
0.0273
Market Capitalization
12.5 B
Enterprise Value Revenue
1.1484
Revenue
19.4 B
There are over one hundred nineteen available fundamental signals for Fresenius Medical Care, which can be analyzed over time and compared to other ratios. All traders should verify Fresenius Medical's prevailing fundamentals against the performance from 2010 to 2024 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 9.1 B in 2024, whereas Enterprise Value is likely to drop slightly above 13.9 B in 2024.

Fresenius Medical Total Revenue

11.38 Billion

Check Fresenius Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fresenius Medical's main balance sheet or income statement drivers, such as Interest Expense of 234.9 M, Total Revenue of 11.4 B or Gross Profit of 3.7 B, as well as many indicators such as Price To Sales Ratio of 0.28, Dividend Yield of 0.0612 or PTB Ratio of 0.39. Fresenius financial statements analysis is a perfect complement when working with Fresenius Medical Valuation or Volatility modules.
  
Check out the analysis of Fresenius Medical Correlation against competitors.

Fresenius Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding405.8 M293.4 M479.5 M
Slightly volatile
Total Assets18.7 B33.9 B24.1 B
Slightly volatile
Short and Long Term Debt Total6.2 B12.1 B8.6 B
Slightly volatile
Other Current Liabilities3.8 B3.6 B2.1 B
Slightly volatile
Total Current Liabilities3.6 B6.1 B4.6 B
Slightly volatile
Total Stockholder Equity7.8 B13.6 B10 B
Slightly volatile
Property Plant And Equipment Net7.8 B7.5 B4 B
Slightly volatile
Net Debt5.7 B10.6 B7.7 B
Slightly volatile
Retained Earnings11.5 B10.9 B7.6 B
Slightly volatile
Accounts Payable550.9 M885.1 M677 M
Slightly volatile
Cash1.5 B1.4 B931.7 M
Slightly volatile
Non Current Assets Total13.8 B25.2 B17.9 B
Slightly volatile
Non Currrent Assets Other212.4 M223.6 M1.3 B
Slightly volatile
Cash And Short Term Investments1.6 B1.5 B1 B
Slightly volatile
Net Receivables2.6 B4.1 B3.3 B
Slightly volatile
Common Stock Total Equity304.7 M336.8 M300.8 M
Slightly volatile
Liabilities And Stockholders Equity18.7 B33.9 B24.1 B
Slightly volatile
Non Current Liabilities Total7.2 B13 B9.3 B
Slightly volatile
Inventory2.3 B2.2 B1.4 B
Slightly volatile
Other Current Assets348.1 M332.6 M364.7 M
Pretty Stable
Other Stockholder Equity3.2 B3.4 B3.3 B
Slightly volatile
Total Liabilities10.8 B19.1 B13.9 B
Slightly volatile
Property Plant And Equipment Gross17 B17.9 B5.6 B
Slightly volatile
Total Current Assets4.9 B8.7 B6.1 B
Slightly volatile
Short Term Debt1.1 B1.6 B1.4 B
Slightly volatile
Intangible Assets1.7 B1.4 B1.6 B
Slightly volatile
Common Stock258.6 M337.4 M278.9 M
Slightly volatile
Other Liabilities3.2 B3.1 B1.9 B
Slightly volatile
Other Assets1.4 B1.3 B771 M
Slightly volatile
Long Term Debt5.7 B7 B6.4 B
Pretty Stable
Property Plant Equipment10.1 B9.6 B5.3 B
Slightly volatile
Good Will13.9 B14.7 B11.5 B
Slightly volatile
Short Term Investments140.2 M136.3 M113.5 M
Slightly volatile
Long Term Investments853.1 M1.3 B758.5 M
Slightly volatile
Short and Long Term Debt1.7 B944.6 M3.3 B
Slightly volatile
Long Term Debt Total9.4 B12.9 B8.4 B
Slightly volatile
Capital Surpluse2.9 B3 B3.7 B
Slightly volatile
Net Invested Capital20.3 B21.5 B18 B
Pretty Stable
Cash And Equivalents422 M326.5 M427.9 M
Pretty Stable
Net Working Capital1.4 B2.6 B1.2 B
Slightly volatile
Capital Stock238 M264.1 M297.1 M
Slightly volatile

Fresenius Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Revenue11.4 B19.5 B14.4 B
Slightly volatile
Gross Profit3.7 B4.9 B4.6 B
Slightly volatile
EBITDA2.1 B3.4 B2.5 B
Very volatile
Net Income712.5 M499 M938.2 M
Pretty Stable
Depreciation And Amortization1.7 B1.6 B987.5 M
Slightly volatile
Selling General Administrative3 B3.2 B2.6 B
Slightly volatile
Other Operating Expenses10.2 B18 B12.7 B
Slightly volatile
Research Development243.6 M232 M148.2 M
Slightly volatile
Cost Of Revenue8 B14.5 B10 B
Slightly volatile
Total Operating Expenses2.2 B3.4 B2.7 B
Slightly volatile
Income Before Tax1.2 B911 M1.5 B
Pretty Stable
Net Income Applicable To Common Shares931.7 M774.4 M1 B
Very volatile
Net Income From Continuing Ops1.1 B732.5 M1.4 B
Pretty Stable
Tax Provision357.8 M300.6 M480.6 M
Slightly volatile
Interest Income83.8 M88.2 M297.6 M
Slightly volatile
Reconciled Depreciation1.6 B1.8 B1.1 B
Slightly volatile

Fresenius Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow1.3 B1.3 B863.9 M
Slightly volatile
Depreciation1.8 B1.8 B1 B
Slightly volatile
Capital Expenditures1 B684.6 M1.4 B
Pretty Stable
Total Cash From Operating Activities1.5 B2.6 B2 B
Slightly volatile
Net Income848 M499 M1.1 B
Pretty Stable
End Period Cash Flow1.5 B1.4 B934.9 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.280.291.0252
Slightly volatile
Dividend Yield0.06120.05830.0294
Slightly volatile
PTB Ratio0.390.41421.5652
Slightly volatile
Days Sales Outstanding64.5776.186681.1317
Slightly volatile
Book Value Per Share53.0650.531227.5568
Slightly volatile
Operating Cash Flow Per Share9.418.95945.3473
Slightly volatile
Average Payables746.3 M710.7 M660.4 M
Slightly volatile
Capex To Depreciation0.370.39081.7495
Slightly volatile
PB Ratio0.390.41421.5652
Slightly volatile
EV To Sales0.80.83721.5483
Slightly volatile
Inventory Turnover9.356.66727.9127
Slightly volatile
Net Income Per Share1.11.70072.0602
Slightly volatile
Days Of Inventory On Hand35.354.745647.0571
Slightly volatile
Payables Turnover11.4616.414214.4059
Pretty Stable
Average Inventory1.2 B1.2 B1.1 B
Slightly volatile
Research And Ddevelopement To Revenue0.0070.01190.0092
Slightly volatile
Capex To Revenue0.06250.03520.0983
Slightly volatile
Cash Per Share5.515.24782.7173
Slightly volatile
POCF Ratio2.042.14588.4795
Slightly volatile
Payout Ratio0.440.65860.4799
Pretty Stable
Capex To Operating Cash Flow0.250.26040.78
Slightly volatile
Days Payables Outstanding29.3622.236925.3907
Pretty Stable
Income Quality5.535.26813.0067
Pretty Stable
ROE0.07270.03660.0927
Slightly volatile
EV To Operating Cash Flow5.896.195912.5375
Slightly volatile
PE Ratio10.7411.304417.234
Slightly volatile
Return On Tangible Assets0.02650.02780.0773
Slightly volatile
Earnings Yield0.04780.08850.0744
Slightly volatile
Intangibles To Total Assets0.580.47190.518
Slightly volatile
Net Debt To EBITDA2.053.09633.3403
Slightly volatile
Current Ratio1.121.42381.408
Slightly volatile
Receivables Turnover5.024.79094.5108
Slightly volatile
Graham Number44.2542.145734.558
Slightly volatile
Shareholders Equity Per Share48.7446.4226.9155
Slightly volatile
Debt To Equity0.580.88470.8297
Very volatile
Capex Per Share1.682.33323.2935
Slightly volatile
Average Receivables3.7 B3.5 B3.3 B
Slightly volatile
Revenue Per Share69.6266.302337.9376
Slightly volatile
Interest Debt Per Share44.3342.214924.7403
Slightly volatile
Debt To Assets0.240.35520.3416
Very volatile
Enterprise Value Over EBITDA6.944.73679.1712
Slightly volatile
Short Term Coverage Ratios2.171.68341.9375
Slightly volatile
Price Earnings Ratio10.7411.304417.234
Slightly volatile
Operating Cycle99.86131128
Pretty Stable
Price Book Value Ratio0.390.41421.5652
Slightly volatile
Days Of Payables Outstanding29.3622.236925.3907
Pretty Stable
Dividend Payout Ratio0.440.65860.4799
Pretty Stable
Price To Operating Cash Flows Ratio2.042.14588.4795
Slightly volatile
Pretax Profit Margin0.080.04680.1052
Slightly volatile
Effective Tax Rate0.390.33040.3263
Slightly volatile
Company Equity Multiplier2.652.49112.434
Very volatile
Long Term Debt To Capitalization0.290.43510.4041
Pretty Stable
Total Debt To Capitalization0.330.46940.4468
Very volatile
Debt Equity Ratio0.580.88470.8297
Very volatile
Quick Ratio1.241.06721.1424
Slightly volatile
Dividend Paid And Capex Coverage Ratio1.552.59451.2764
Slightly volatile
Net Income Per E B T0.460.54770.5591
Pretty Stable
Cash Ratio0.240.22960.1819
Slightly volatile
Cash Conversion Cycle78.51109103
Very volatile
Operating Cash Flow Sales Ratio0.0960.13510.1298
Pretty Stable
Days Of Inventory Outstanding35.354.745647.0571
Slightly volatile
Days Of Sales Outstanding64.5776.186681.1317
Slightly volatile
Cash Flow Coverage Ratios0.330.21820.2374
Pretty Stable
Price To Book Ratio0.390.41421.5652
Slightly volatile
Fixed Asset Turnover2.482.60994.2579
Slightly volatile
Capital Expenditure Coverage Ratio2.053.83991.6299
Slightly volatile
Price Cash Flow Ratio2.042.14588.4795
Slightly volatile
Enterprise Value Multiple6.944.73679.1712
Slightly volatile
Debt Ratio0.240.35520.3416
Very volatile
Cash Flow To Debt Ratio0.330.21820.2374
Pretty Stable
Price Sales Ratio0.280.291.0252
Slightly volatile
Return On Assets0.0140.01470.0376
Slightly volatile
Asset Turnover0.730.57340.6192
Pretty Stable
Net Profit Margin0.04560.02570.0638
Slightly volatile
Gross Profit Margin0.360.25320.3241
Slightly volatile
Price Fair Value0.390.41421.5652
Slightly volatile
Return On Equity0.07270.03660.0927
Slightly volatile

Fresenius Medical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap9.1 B5.6 B14 B
Slightly volatile
Enterprise Value13.9 B16.3 B21.8 B
Pretty Stable

Fresenius Fundamental Market Drivers

Forward Price Earnings11.2867
Cash And Short Term Investments1.5 B

Fresenius Upcoming Events

20th of February 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Fresenius Medical Financial Statements

Fresenius Medical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Fresenius Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Fresenius Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Fresenius Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue85.8 M81.5 M
Total Revenue19.5 B11.4 B
Cost Of Revenue14.5 B8 B
Research And Ddevelopement To Revenue 0.01  0.01 
Capex To Revenue 0.04  0.06 
Revenue Per Share 66.30  69.62 
Ebit Per Revenue 0.08  0.13 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Fresenius Stock Analysis

When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY